David Pascoe
David Pascoe started the Rosacea Support Group in October 1998.

Galderma has announced that Epsolay has been approved by the FDA for treating rosacea. Epsolay is a proprietary cream formulation of benzoyl peroxide, 5%, designated for the treatment of inflammatory lesions of rosacea in adults. In July 2021 Galderma announced an exclusive 5 year deal to market Epsolay in the US. The creators of Epsolay […]

In 2017, the FDA approved the extended release formulation of minocycline, known as Minolira, for the treatment of severe acne vulgaris. The modified release formulation of doxycycline known as Oracea, was approved for the treatment of rosacea in 2006. As minocycline and doxycycline are related tetracyclines, Minolira may offer rosacea sufferers another rosacea treatment option, […]

The yet to be approved `encapsulated’ Benzoyl Peroxide 5% Cream known as Epsolay has received a huge promotional boost after the rosacea heavyweight Galderma announced a 5 year exclusive license for the US market. Having the backing of a significant licensing deal from Galderma behind them is good news for the owners of Epsolay. The […]

Teva Generics has announced that they are now selling a generic version of Soolantra, branded as Ivermectin Cream 1%. This generic formulation of Ivermectin is indicated for the treatment of inflammatory lesions of rosacea – that is the papules and pustules common to rosacea sufferers. Teva Announces the U.S. Launch of its Generic Version of […]